Navigation Links
IDEXX Laboratories Announces Fourth Quarter and Full Year Results
Date:1/27/2012

rily from higher sales and marketing personnel-related costs, partly offset by an incremental milestone payment earned during the quarter related to the 2008 sale of product rights previously included in our pharmaceutical product line, which was recorded as a reduction in expense. Research and development ("R&D") expense for the fourth quarter of 2011 was $20.2 million, or 7% of revenue, compared to $17.5 million, or 6% of revenue for the fourth quarter of 2010. The increase in R&D expense resulted primarily from increased personnel-related costs and higher external consulting and development costs.

Year-to-Date Results Revenues for the year ended December 31, 2011 increased 10% to $1.219 billion, from $1.103 billion for the year ended December 31, 2010. Organic revenue growth for the year ended December 31, 2011 was 8%. Changes in foreign currency exchange rates contributed 2% to revenue growth and revenue from acquisitions contributed less than 1% to revenue growth for the year ended December 31, 2011.

EPS for the year ended December 31, 2011 increased 17% to $2.78, compared to $2.37 for the same period in the prior year. 2011 EPS includes an aggregate of $4 million in payments relating to the sale of certain product rights and to the sale of certain raw material inventory in connection with the 2008 restructuring of our pharmaceutical business, which added $0.04 to EPS. 2010 EPS included similar milestone payments, which added $0.03 to EPS.

Supplementary Analysis of ResultsThe accompanying financial tables provide more information concerning our revenue and other operating results for the three and twelve months ended December 31, 2011.

Outlook for 2012The Company provides the following updated guidance for the full year of 2012. This guidance reflects an assumption that the value of the U.S. dollar relative to other currencies will remain at our current assumptions of the euro at $1.25, the British pound at $1.53 and
'/>"/>

SOURCE IDEXX Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. IDEXX Laboratories to Release 2009 Fourth Quarter and Full-Year Financial Results
2. IDEXX Laboratories Announces Catalyst Dx(R) Placement Total for 2009 and Installed Base of SmartService(TM) Customers
3. McAllister Software Systems, Inc. and IDEXX Laboratories, Inc. Announce Availability of the IDEXX VetLab(R) Station InterLink(TM) Connection to AVImark(R) 2010
4. NetMotion Wireless Tapped by IDEXX Laboratories to Provide Secure Mobile Access to Field Personnel
5. IDEXX Laboratories to Release 2011 Second Quarter Financial Results
6. IDEXX Laboratories Announces Third Quarter Results
7. IDEXX Laboratories to Present at J.P. Morgan Healthcare Conference
8. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
9. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
10. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
11. Romark Laboratories Raises $18 Million in Institutional Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , Oct. 1, 2014 ... now available. Interested parties can learn about ... Cardinal Health is supporting the health care ... http://cardinalhealth.com/annualreport . Photo- http://photos.prnewswire.com/prnh/20140930/149504-INFO ... summary financials and the chief executive officer,s ...
(Date:10/1/2014)... , Oct. 1, 2014  Dyadic International, ... with patented and proprietary technology used to develop ... bioenergy, bio-based chemicals, biopharmaceuticals, and industrial enzymes industries, ... payment from Abengoa Bioenergy for commercial scale production ... biomass into ethanol, developed under Abengoa,s license agreement ...
(Date:10/1/2014)... , Oct. 1, 2014  ResMed (NYSE: ... and the first company to design complete sleep apnea solutions ... women about the importance of a good night,s sleep. ... challenge the myth that feeling tired is just part of ... that sleep is a critical pillar of health, essential to ...
Breaking Medicine Technology:Cardinal Health 2014 Digital Report to Shareholders Now Available 2Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 2Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 3ResMed Launches Initiative to Help Women Get Better Sleep 2ResMed Launches Initiative to Help Women Get Better Sleep 3
... LONDON, Nov. 11, 2010 UK based Trimega Laboratories is ... met the standards set by the prestigious Investors in People ... by the Employer Representative Quality Board of IIP and reflects ... an organization. A significant aspect of the achievement is that, ...
... Inc. (OTCQB: ILIU) today announced financial and operational results for ... for the three months ended September 30, 2010 was $0.5 ... the prior year. The increase was primarily attributable to greater ... Research and development expenses were $0.4 million for the three ...
Cached Medicine Technology:IIP Recognition for Substance Abuse Testing Lab Trimega Laboratories 2Interleukin Genetics Reports Third Quarter 2010 Financial Results 2Interleukin Genetics Reports Third Quarter 2010 Financial Results 3Interleukin Genetics Reports Third Quarter 2010 Financial Results 4Interleukin Genetics Reports Third Quarter 2010 Financial Results 5
(Date:10/1/2014)... strongly associated with Alzheimer,s disease; however, researchers are still ... causal agent of the onset and development of the ... beta-amyloid is not harmful when found in isolation but ... to form the so-called amyloid fibrils , "We are ... with multiple ones because each aggregate of peptide, which ...
(Date:10/1/2014)... October 1, 2014 Patients with increased inflammation, ... a greatly increased risk of depression. For example, ... chronic hepatitis C virus infection causes depression in ... acids, more commonly known as fish oil, have ... the risk of heart disease and reducing triglyceride ...
(Date:10/1/2014)... 01, 2014 Insuranceragents.info has released ... good life insurance plan for vulnerable family members. , ... family members. Providers in the family should always carry ... financial hardships for the rest of the family. ... Families can benefit more from temporary coverage or from ...
(Date:10/1/2014)... ATLANTA (PRWEB) October 01, 2014 ... executive networking and relationship-marketing firm, announced today ... Security Executive® and Project of the Year ... decision makers representing organizations in financial services, ... include large-scale technology endeavors that address key ...
(Date:10/1/2014)... 01, 2014 Between 23 million and ... U.S., according to figures from the National Institutes of ... (AARDA), and many of them have something else in ... undiagnosed celiac disease. Gluten Free Therapeutics, makers of ... undiagnosed celiac disease by publishing a series of blog ...
Breaking Medicine News(10 mins):Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2Health News:Omega-3 fatty acids may prevent some forms of depression 2Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3
... announced a pre-approval program to compliment the Small Business Administration,s recent ... remove fees charged to banks and make it easier for entrepreneurs ... ... St. Louis, MO (PRWEB) April 7, 2009 -- Health Career ...
... April 7 Leading Sucralose manufacturer Guangdong Food ... announced that the U.S. International Trade Commission (ITC) ... a Section 337 patent dispute (docket no. 337-TA-604) ... & Lyle Corporation (T&L). Mr. Wang Sanyong, ...
... Acupuncture cannot be shown to have any positive effect on ... a systematic review of literature by three groups in Daejon, ... edition of the peer-reviewed journal Climacteric . , Many ... use, but still have to deal with the symptoms which ...
... of corporate training software and solutions, has partnered with Medcom ... courses to CERTPOINTVLS™ users. , ... ... provider of corporate training software and solutions, today announced they ...
... Inc., a global provider of image management services for biopharmaceutical and ... an agreement with AG Mednet, a HIPAA and 21 CFR Part ... to offer clinical trial sponsors more options for efficient, cost-effective image ... ...
... software to an assisted medical billing process providing the medical ... ... (Vocus) April 7, 2009 -- Glenwood Systems LLC announced today the ... efficiencies and improve physician revenue in an office based medical practice. ...
Cached Medicine News:Health News:Health Career Agents Announces SBA Pre-Approval Program to Launch a Healthcare Recruiting Business 2Health News:Health Career Agents Announces SBA Pre-Approval Program to Launch a Healthcare Recruiting Business 3Health News:GDFII/L&P Sucralose Win Over Competitor Tate & Lyle 2Health News:GDFII/L&P Sucralose Win Over Competitor Tate & Lyle 3Health News:Acupuncture 'probably ineffective' in treatment of hot flushes 2Health News:CERTPOINT Systems Partners with Medcom Trainex, Inc. to Offer Extensive Library of Healthcare Courses -- Professionals in Healthcare sector to benefit from online educational courses 2Health News:CERTPOINT Systems Partners with Medcom Trainex, Inc. to Offer Extensive Library of Healthcare Courses -- Professionals in Healthcare sector to benefit from online educational courses 3Health News:CERTPOINT Systems Partners with Medcom Trainex, Inc. to Offer Extensive Library of Healthcare Courses -- Professionals in Healthcare sector to benefit from online educational courses 4Health News:M2S Announces Agreement with AG Mednet to Provide Clinical Trial Sponsors with More Options for Efficient Image Transfer and Collection 2Health News:M2S Announces Agreement with AG Mednet to Provide Clinical Trial Sponsors with More Options for Efficient Image Transfer and Collection 3Health News:Glenwood Systems, LLC Releases EMR Practice Management and Medical Billing Process Improvement Program 2Health News:Glenwood Systems, LLC Releases EMR Practice Management and Medical Billing Process Improvement Program 3
Two point fixation, tips separated by 13 mm. Each tip has 0.12 mm, 1 x 2 teeth. Wide serrated handle with thumb catch lock and dull finish....
Magnetic Farnsworth D15 kit Magnets move the color disks. Protects disks from fingerprints. Keeps all the disks in one place. Clear glass insures accurate color perception. Makes color testing fun....
... the Farnsworth-Munsell 100 Hue Test. It is intended ... study of a color vision defect. It provides ... difficulty in distinguishing color differences in certain tasks. ... reference caps with Munsell notations, plus a neutral ...
Spanish HRR/Amsler combination with Spanish and English directions for both HRR and amsler tests plus occluding glasses....
Medicine Products: